Zanubrutinib Combined With G-CVP in Previously Untreated FL

NCT06959732 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma ( FL)

Interventions

DRUG: zanubrutinib, obinutuzumab,combined with CVP

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences